Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Bangladesh
  4. Dhaka Stock Exchange
  5. Beximco Pharmaceuticals Limited
  6. News
  7. Summary
    BXPHARMA   BD0453BXPH04

BEXIMCO PHARMACEUTICALS LIMITED

(BXPHARMA)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Beximco Pharmaceuticals : Receives Next Shipment For COVID-19 Vaccine To Distribute To Bangladesh

10/11/2021 | 04:51am EST


ę MT Newswires 2021
All news about BEXIMCO PHARMACEUTICALS LIMITED
04:52aBeximco Jumps 6% on License to Produce Merck & Co.'s COVID-19 Drug in Bangladesh
MT
04:40aDozens of firms to make cheap version of Merck COVID pill for poorer nations
RE
2021Beximco Pharma introduces world's first generic version of Pfizer's Paxlovid, the first..
AQ
2021Beximco Pharmaceuticals Launches Generic Version Of Pfizer's COVID-19 Pill
MT
2021Beximco Pharmaceuticals Limited Launches First Generic Version of Pfizer's COVID-19 Tre..
CI
2021Beximco Pharmaceuticals Limited Approves Cash Dividend for the Year Ended on 30 June 20..
CI
2021Beximco Pharmaceuticals Receives COVID-19 Shots Shipment For Distribution In Bangladesh
MT
2021Beximco Receives COVID-19 Shots for Distribution in Bangladesh
MT
2021Beximco Says No Confirmation from Serum Institute on Resumption of COVID-19 Vaccine Del..
MT
2021BEXIMCO PHARMACEUTICALS LIMITED : Ex-dividend day for final dividend
FA
More news
Financials
Sales 2022 32 835 M 387 M 387 M
Net income 2022 5 270 M 62,2 M 62,2 M
Net Debt 2022 8 680 M 102 M 102 M
P/E ratio 2022 15,7x
Yield 2022 1,94%
Capitalization 89 579 M 1 049 M 1 057 M
EV / Sales 2022 2,99x
EV / Sales 2023 2,33x
Nbr of Employees 5 500
Free-Float 94,3%
Chart BEXIMCO PHARMACEUTICALS LIMITED
Duration : Period :
Beximco Pharmaceuticals Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus SELL
Number of Analysts 2
Last Close Price 200,80 BDT
Average target price 153,00 BDT
Spread / Average Target -23,8%
EPS Revisions
Managers and Directors
Nazmul Hassan Chief Executive Officer, Director & MD
Ali Nawaz Chief Financial Officer
Ahmed Sohail Fasihur Rahman Chairman
Selina Akter Executive Director-Medical Affairs Department
Rabbur Reza Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
BEXIMCO PHARMACEUTICALS LIMITED4.20%1 024
JOHNSON & JOHNSON-2.62%438 538
ROCHE HOLDING AG-3.53%323 214
PFIZER, INC.-9.33%300 513
ABBVIE INC.-0.14%239 035
NOVO NORDISK A/S-12.67%223 059